| Literature DB >> 35372724 |
Amreen Farooqui1, Mehmet S Albayram2, Varalakshmi Ballur Narayana Reddy1, Nandakumar Nagaraja1.
Abstract
OBJECTIVES: Lacunar strokes can have fluctuations and progression in the acute period leading to poor outcomes. Our study sought to evaluate if, in lacunar strokes, neurological deterioration (ND) was associated with blood pressure (BP) variations, stroke size, or increased time to peak (TTP) on admission computed tomography perfusion (CTP).Entities:
Keywords: Computed tomography perfusion; ischemic stroke; neurological deterioration; time to peak
Year: 2022 PMID: 35372724 PMCID: PMC8973445 DOI: 10.4103/bc.bc_68_21
Source DB: PubMed Journal: Brain Circ ISSN: 2394-8108
Figure 1Diffusion-weighted imaging and computed tomography perfusion of a 71-year-old woman with right leg weakness and no neurological deterioration. Admission modified National Institutes of Health Stroke Scale was 1 for right leg weakness. Patient was treated with clopidogrel. diffusion-weighted imaging performed 28 h from last known well showed acute ischemic stroke in the left pons (a) with corresponding increased time to peak on Computed tomography perfusion (b) performed 32 h from last known well
Figure 2Diffusion-weighted imaging and Computed tomography perfusion of a 84-year-old woman with right side weakness and neurological deterioration. Admission modified National Institutes of Health Stroke Scale was 3 (1 point for right arm and 2 points for right leg). Patient was treated with aspirin and clopidogrel. Right side weakness worsened on day 2. diffusion-weighted imaging performed 14 h from last known well showed acute ischemic stroke in the left thalamus and posterior limb of internal capsule (a and b) with corresponding increased time to peak on Computed tomography perfusion (c and d) performed 6 h from last known well
Clinical characteristics
| Variable | ND |
| |
|---|---|---|---|
|
| |||
| Yes ( | No ( | ||
| Age (years), mean±SD | 65±13 | 62±15 | 0.50 |
| Sex (female) | 10 (53) | 15 (50) | 0.86 |
| Race | |||
| White | 13 (68) | 20 (67) | 0.90 |
| Nonwhite | 6 (32) | 10 (33) | |
| Past medical history | |||
| Hypertension | 16 (84) | 25 (83) | 0.94 |
| Diabetes mellitus | 11 (58) | 13 (43) | 0.32 |
| Hyperlipidemia | 7 (37) | 12 (40) | 0.83 |
| Stroke | 6 (32) | 6 (20) | 0.50 |
| Atrial fibrillation | 0 (0) | 2 (7) | 0.51 |
| Coronary artery disease | 2 (11) | 4 (13) | 1.00 |
| Congestive heart failure | 1 (5) | 1 (3) | 1.00 |
| Peripheral vascular disease | 0 | 1 (3) | 1.00 |
| Social history | |||
| Tobacco use | 11 (58) | 13 (43) | 0.32 |
| Alcohol use | 7 (37) | 9 (30) | 0.62 |
| Admission vital signs (mmHg), mean±SD | |||
| SBP | 151±16 | 151±19 | 0.96 |
| DBP | 80±14 | 81±15 | 0.70 |
| MAP | 103±13 | 104±15 | 0.91 |
| Change in BP from day of admission to ND | |||
| Decrease in SBP ≥10 mmHg | 4 (21) | 10 (33) | 0.35 |
| Decrease in DBP ≥5 mmHg | 5 (26) | 7 (23) | 1.00 |
| Decrease in MAP ≥5 mmHg | 7 (37) | 11 (37) | 0.99 |
| Total NIHSS score, median (IQR) | 3 (1-5) | 3 (1-4) | 0.81 |
| Modified NIHSS score, median (IQR) | 2 (1-4) | 2 (0-3) | 0.54 |
| Head of bed flat | 5 (26) | 1 (3) | 0.03 |
| Intravenous fluids | 18 (95) | 25 (83) | 0.38 |
| Alteplase use | 2 (11) | 3 (10) | 1.00 |
| Antiplatelets | |||
| Aspirin | 14 (74) | 28 (93) | 0.09 |
| Clopidogrel | 13 (68) | 15 (50) | 0.20 |
| Aspirin and clopidogrel | 8 (42) | 13 (43) | 0.93 |
| Last known well to CT perfusion time (h), median (IQR) | 15 (6-20) | 14 (5-32) | 0.79 |
| Last known well to brain MRI time (h), median (IQR) | 21 (15-27) | 22 (17-35) | 0.28 |
| Discharge disposition | |||
| Home | 3 (16) | 11 (37) | 0.10 |
| Home with home health care services | 5 (26) | 9 (30) | |
| Acute inpatient rehabilitation | 10 (53) | 6 (20) | |
| Skilled nursing facility | 1 (5) | 4 (13) | |
SD: Standard deviation, IQR: Interquartile range, NIHSS: National Institutes of Health Stroke Scale, ND: Neurological deterioration, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, MAP: Mean arterial blood pressure, CT=Computed tomography, MRI=Magnetic resonance imaging
Imaging characteristics
| Variable | ND |
| |
|---|---|---|---|
|
| |||
| Yes ( | No ( | ||
| Stroke location ( | |||
| Putamen | 2 | 1 | 0.55 |
| Globus pallidus | 0 | 1 | 1.00 |
| Internal capsule | 8 | 8 | 0.35 |
| Caudate | 1 | 0 | 0.39 |
| Thalamus | 3 | 11 | 0.19 |
| Corona radiata | 7 | 10 | 1.00 |
| Midbrain | 1 | 1 | 1.00 |
| Pons | 3 | 8 | 0.49 |
| Medulla | 1 | 0 | 0.39 |
| Stroke size (mm), median (IQR) | 14 (8-15) | 13 (10-17) | 0.43 |
| Stroke size, ≤10 mm, | 12 (63) | 19 (63) | 0.99 |
| Increase in time to peak in stroke area, | 12 (63) | 11 (37) | 0.07 |
| Increase in cerebral blood volume in stroke area, | 3 (16) | 1 (3) | 0.28 |
| Decrease in cerebral blood volume in stroke area, | 1 (5) | 3 (10) | 1.00 |
*Some patients had stroke extending to adjoining locations listed. IQR: Interquartile range, ND: Neurological deterioration
Figure 3Diffusion-weighted imaging and Computed tomography perfusion of a 48-year-old man with left side weakness and no neurological deterioration. Admission modified National Institutes of Health Stroke Scale was 9 (3 points for left arm, 4 for left leg, 1 each for sensory and facial droop). Patient was treated with alteplase and later started on aspirin. diffusion-weighted imaging performed 20 h from last known well showed stroke in the right corona radiata (a) without any change in time to peak on computed tomography perfusion (b and c) performed 1 h from last known well
Multivariate logistic regression analysis for predictors of neurological deterioration
| Variable | OR (95% CI) |
|
|---|---|---|
| Age | 1.03 (0.98-1.08) | 0.27 |
| Gender | 1.29 (0.31-5.46) | 0.73 |
| Race | 0.31 (0.05-1.82) | 0.20 |
| Decrease in SBP ≥10 mmHg | 0.35 (0.07-1.82) | 0.21 |
| Decrease in DBP ≥5 mmHg | 1.97 (0.38-10.37) | 0.42 |
| Modified NIHSS | 1.09 (0.79-1.49) | 0.61 |
| Increase in TTP | 4.80 (1.15-20.10) | 0.03* |
| Stroke size | 0.89 (0.75-1.06) | 0.18 |
| Dual antiplatelets (aspirin and clopidogrel) | 1.02 (0.25-4.15) | 0.98 |
*P<0.05. Model c-statistic 0.758, Hosmer and Lemeshow Goodness-of-fit test 0.916. OR: Odds ratio, CI: Confidence interval, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, NIHSS: National Institutes of Health Stroke Scale, TTP: Time to peak